| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2023-05-05 12:01:03 UTC |
|---|
| Updated at | 2025-02-11 15:45:52 UTC |
|---|
| NP-MRD ID | NP0331617 |
|---|
| Natural Product DOI | https://doi.org/10.57994/0605 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | 3-epi-notoamide C |
|---|
| Description | Notoamide C belongs to the class of organic compounds known as 2,2-dimethyl-1-benzopyrans. These are organic compounds containing a 1-benzopyran moiety that carries two methyl groups at the 2-position. Notoamide C is a secondary metabolite. Secondary metabolites are metabolically or physiologically non-essential metabolites that may serve a role as defense or signalling molecules. In some cases they are simply molecules that arise from the incomplete metabolism of other secondary metabolites. 3-epi-notoamide C was first documented in 2014 (PMID: 24532297). Based on a literature review a significant number of articles have been published on notoamide C (PMID: 26061478) (PMID: 32672903) (PMID: 36334789) (PMID: 34999079) (PMID: 37097072). |
|---|
| Structure | [H][C@@]12CCCN1C(=O)[C@]([H])(C[C@]1(C(=O)NC3=C1C=CC1=C3C=CC(C)(C)O1)C(C)(C)C=C)NC2=O InChI=1S/C26H31N3O4/c1-6-24(2,3)26(14-17-22(31)29-13-7-8-18(29)21(30)27-17)16-9-10-19-15(20(16)28-23(26)32)11-12-25(4,5)33-19/h6,9-12,17-18H,1,7-8,13-14H2,2-5H3,(H,27,30)(H,28,32)/t17-,18-,26-/m0/s1 |
|---|
| Synonyms | Not Available |
|---|
| Chemical Formula | C26H31N3O4 |
|---|
| Average Mass | 449.5510 Da |
|---|
| Monoisotopic Mass | 449.23146 Da |
|---|
| IUPAC Name | Not Available |
|---|
| Traditional Name | Not Available |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | [H][C@@]12CCCN1C(=O)[C@]([H])(C[C@]1(C(=O)NC3=C1C=CC1=C3C=CC(C)(C)O1)C(C)(C)C=C)NC2=O |
|---|
| InChI Identifier | InChI=1S/C26H31N3O4/c1-6-24(2,3)26(14-17-22(31)29-13-7-8-18(29)21(30)27-17)16-9-10-19-15(20(16)28-23(26)32)11-12-25(4,5)33-19/h6,9-12,17-18H,1,7-8,13-14H2,2-5H3,(H,27,30)(H,28,32)/t17-,18-,26-/m0/s1 |
|---|
| InChI Key | KNFZHRYXLWKRSU-XWXLMPLOSA-N |
|---|
| Experimental Spectra |
|---|
|
| | Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
|---|
| | Predicted Spectra |
|---|
|
| Not Available | | Chemical Shift Submissions |
|---|
|
| | Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 1H NMR Spectrum (1D, 400, C3D6O, simulated) | zhangcuixian@gzucm.edu.cn | guangzhou university of Chinese medicine | zhangcuixian | 2024-05-11 | View Spectrum |
| | Species |
|---|
| Species of Origin | | Species Name | Source | Reference |
|---|
| Aspergillus versicolor CGF 9-1-2 | | |
|
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as 2,2-dimethyl-1-benzopyrans. These are organic compounds containing a 1-benzopyran moiety that carries two methyl groups at the 2-position. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Benzopyrans |
|---|
| Sub Class | 1-benzopyrans |
|---|
| Direct Parent | 2,2-dimethyl-1-benzopyrans |
|---|
| Alternative Parents | |
|---|
| Substituents | - 2,2-dimethyl-1-benzopyran
- Alpha-amino acid or derivatives
- Indole or derivatives
- Dihydroindole
- Dioxopiperazine
- 2,5-dioxopiperazine
- Alkyl aryl ether
- N-alkylpiperazine
- 1,4-diazinane
- Benzenoid
- Piperazine
- Tertiary carboxylic acid amide
- Pyrrolidine
- Carboxamide group
- Lactam
- Secondary carboxylic acid amide
- Azacycle
- Ether
- Carboxylic acid derivative
- Oxacycle
- Organic oxide
- Organic oxygen compound
- Hydrocarbon derivative
- Organic nitrogen compound
- Carbonyl group
- Organonitrogen compound
- Organooxygen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - Wang B, Park EM, King JB, Mattes AO, Nimmo SL, Clendinen C, Edison AS, Anklin C, Cichewicz RH: Transferring Fungi to a Deuterium-Enriched Medium Results in Assorted, Conditional Changes in Secondary Metabolite Production. J Nat Prod. 2015 Jun 26;78(6):1415-21. doi: 10.1021/acs.jnatprod.5b00337. Epub 2015 Jun 10. [PubMed:26061478 ]
- Gao S, Tian WJ, Liao ZJ, Wang GH, Zeng DQ, Liu XZ, Wang XY, Zhou H, Chen HF, Lin T: Chemical Constituents from Endophytic Fungus Annulohypoxylon cf. stygium in Leaves of Anoectochilus roxburghii. Chem Biodivers. 2020 Sep;17(9):e2000424. doi: 10.1002/cbdv.202000424. Epub 2020 Aug 31. [PubMed:32672903 ]
- Dai JM, Mi QL, Li XM, Gang D, Yang GY, Zhang JD, Wang J, Li YK, Yang HY, Miao D, Li ZJ, Hu QF: The anti-TMV potency of the tobacco-derived fungus Aspergillus versicolor and its active alkaloids, as anti-TMV activity inhibitors. Phytochemistry. 2023 Jan;205:113485. doi: 10.1016/j.phytochem.2022.113485. Epub 2022 Nov 5. [PubMed:36334789 ]
- Gao Y, Meng Q, Zhou X, Luo X, Su Z, Chen Z, Huang R, Liu Y, Zhang X: How do environmentally friendly antifouling alkaloids affect marine fouling microbial communities? Sci Total Environ. 2022 May 10;820:152910. doi: 10.1016/j.scitotenv.2021.152910. Epub 2022 Jan 6. [PubMed:34999079 ]
- Zhang XY, Xu XY, Peng J, Ma CF, Nong XH, Bao J, Zhang GZ, Qi SH: Antifouling potentials of eight deep-sea-derived fungi from the South China Sea. J Ind Microbiol Biotechnol. 2014 Apr;41(4):741-8. doi: 10.1007/s10295-014-1412-9. Epub 2014 Feb 15. [PubMed:24532297 ]
- Hu JS, He YP, Zhou FG, Wu PP, Chen LY, Ni C, Zhang ZK, Xiao XJ, An LK, He XX, Zhang CX: New Indole Diketopiperazine Alkaloids from Soft Coral-Associated Epiphytic Fungus Aspergillus versicolor CGF 9-1-2. Chem Biodivers. 2023 Jun;20(6):e202300301. doi: 10.1002/cbdv.202300301. Epub 2023 May 17. [PubMed:37097072 ]
- DOI: 10.1002/cbdv.202300301
|
|---|